These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28069611)

  • 21. One-year clinical and computed tomography follow-up after implantation of bioresorbable vascular scaffolds in patients with coronary chronic total occlusions.
    Maeremans J; Verhaert D; Pereira B; Frambach P; Van Mieghem C; Barbato E; Willems E; Vrolix M; Dens J
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):488-496. PubMed ID: 29068171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes of bioresorbable vascular scaffold to treat all-comer patients. Are patients with acute coronary syndrome better candidates for bioresorbable vascular scaffold?
    Picard F; Avram R; Marquis-Gravel G; Tadros VX; Ly HQ; Dorval JF; Doucet S; Gosselin G; Asgar AW; Ibrahim R; Bonan R; de Hemptinne Q; Nosair M; L-L'Allier P; Tanguay JF
    Cardiovasc Revasc Med; 2019 Mar; 20(3):228-234. PubMed ID: 30075958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanded clinical use of everolimus eluting bioresorbable vascular scaffolds for treatment of coronary artery disease.
    Diletti R; Ishibashi Y; Felix C; Onuma Y; Nakatani S; van Mieghem NM; Regar E; Valgimigli M; de Jaegere PP; van Ditzhuijzen N; Fam JM; Ligthart JMR; Lenzen MJ; Serruys PW; Zijlstra F; Jan van Geuns R
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):58-69. PubMed ID: 27896897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of five-year outcome of sirolimus-eluting stent implantation for chronic total occlusions versus for non-chronic total occlusion (from the j-Cypher registry).
    Kato M; Kimura T; Morimoto T; Nishikawa H; Uchida F; Suzuki H; Hayashi Y; Kadota K; Mitsudo K;
    Am J Cardiol; 2012 Nov; 110(9):1282-9. PubMed ID: 22835413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions.
    Fam JM; Ojeda S; Garbo R; Latib A; La Manna A; Vaquerizo B; Boukhris M; Vlachojannis GJ; van Geuns RJ; Ezhumalai B; Kawamoto H; van der Sijde J; Felix C; Pan M; Serdoz R; Boccuzzi GG; De Paolis M; Sardella G; Mancone M; Tamburino C; Smits PC; Di Mario C; Seth A; Serra A; Colombo A; Serruys P; Galassi AR; Zijlstra F; Van Mieghem NM; Diletti R
    EuroIntervention; 2017 Jun; 13(3):355-363. PubMed ID: 28218604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS-save registry.
    Latini RA; Granata F; Ielasi A; Varricchio A; Moscarella E; Tespili M; Cortese B
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):380-7. PubMed ID: 27038332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term clinical outcomes of successful versus unsuccessful revascularization with drug-eluting stents for true chronic total occlusion.
    Lee SW; Lee JY; Park DW; Kim YH; Yun SC; Kim WJ; Suh J; Cho YH; Lee NH; Kang SJ; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2011 Sep; 78(3):346-53. PubMed ID: 21452248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Routine use of optical coherence tomography in bioresorbable vascular scaffold implantation: insights on technique optimization and long-term outcomes.
    Abdelaziz HK; Abuomara HZ; Ali MH; Eichhofer J; Patel B; Saad M
    Coron Artery Dis; 2019 Jun; 30(4):263-269. PubMed ID: 30883433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioresorbable Scaffold for Treatment of Coronary Artery Lesions: Intravascular Ultrasound Results From the ABSORB Japan Trial.
    Okada K; Honda Y; Kitahara H; Otagiri K; Tanaka S; Hollak MB; Yock PG; Popma JJ; Kusano H; Cheong WF; Sudhir K; Fitzgerald PJ; Kimura T;
    JACC Cardiovasc Interv; 2018 Apr; 11(7):648-661. PubMed ID: 29622143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R).
    Nef HM; Wiebe J; Kastner J; Mehilli J; Muenzel T; Naber C; Neumann T; Richardt G; Schmermund A; Woehrle J; Zahn R; Riemer T; Achenbach S; Hamm CW
    EuroIntervention; 2017 Dec; 13(11):1311-1318. PubMed ID: 28829745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous coronary intervention for chronic total occlusion of the coronary artery with the implantation of bioresorbable everolimus-eluting scaffolds. Poznan CTO-Absorb Pilot Registry.
    Lesiak M; Łanocha M; Araszkiewicz A; Siniawski A; Grygier M; Pyda M; Olasińska-Wiśniewska A; Iwanczyk S; Skorupski W; Mitkowski P; Lesiak MB; Grajek S
    EuroIntervention; 2016 Jun; 12(2):e144-51. PubMed ID: 27290673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions.
    Jabbour RJ; Ielasi A; Tanaka A; Leoncini M; Cortese B; Grigis G; Mitomo S; Regazzoli D; Di Palma G; Rapetto C; Tespili M; Colombo A; Latib A
    Cardiovasc Revasc Med; 2017; 18(5S1):S4-S9. PubMed ID: 28314675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions.
    Naganuma T; Kawamoto H; Panoulas VF; Latib A; Tanaka A; Mitomo S; Ruparelia N; Jabbour RJ; Chieffo A; Carlino M; Montorfano M; Colombo A
    Int J Cardiol; 2017 Nov; 246():26-31. PubMed ID: 28867010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-year clinical outcome of patients with chronic total occlusion treated with drug-eluting stents.
    De Felice F; Fiorilli R; Parma A; Nazzaro M; Musto C; Sbraga F; Caferri G; Violini R
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1260-5. PubMed ID: 20129553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) Registry.
    Shen ZJ; García-García HM; Garg S; Onuma Y; Schenkeveld L; van Domburg RT; Serruys PW;
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):979-86. PubMed ID: 19753636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
    Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
    JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres.
    Fabris E; Caiazzo G; Kilic ID; Serdoz R; Secco GG; Sinagra G; Lee R; Foin N; Di Mario C
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):839-46. PubMed ID: 26370357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioresorbable vascular scaffolds in coronary chronic total occlusions: clinical, vasomotor and optical coherence tomography findings at three-year follow-up (ABSORB-CTO study).
    Gheorghe L; Millán X; Jimenez-Kockar M; Gomez-Lara J; Arzamendi D; Danduch L; Agudelo V; Serra A
    EuroIntervention; 2019 May; 15(1):99-107. PubMed ID: 30277460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary chronic total occlusions: mid-term comparison of clinical outcome following the use of the guided-STAR technique and conventional anterograde approaches.
    Godino C; Latib A; Economou FI; Al-Lamee R; Ielasi A; Bassanelli G; Figini F; Chieffo A; Montorfano M; Colombo A; Carlino M
    Catheter Cardiovasc Interv; 2012 Jan; 79(1):20-7. PubMed ID: 21805559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.